Arena Pharmaceuticals, Inc. (ARNA) Stock Rises 5.73% This Week; Should You Buy?

Wednesday, March 09, 2022 10:50 AM | InvestorsObserver Analysts

Mentioned in this article

Arena Pharmaceuticals, Inc. (ARNA) Stock Rises 5.73% This Week; Should You Buy?

Arena Pharmaceuticals, Inc. (ARNA) stock is up 32.37% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ARNA stock a score of 62 out of a possible 100.

That rank is influenced by a long-term technical score of 95. ARNA's rank also includes a short-term technical score of 89. The fundamental score for ARNA is 3. In addition to the average rating from Wall Street analysts, ARNA stock has a mean target price of $93.88. This means analysts expect the stock to lose 5.97% over the next 12 months.

ARNA has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

What's Happening with ARNA Stock Today

Arena Pharmaceuticals, Inc. (ARNA) stock is higher by 1.21% while the S&P 500 is up 2.29% as of 10:49 AM on Wednesday, Mar 9. ARNA is up $1.19 from the previous closing price of $98.64 on volume of 2,859,332 shares. Over the past year the S&P 500 has gained 10.09% while ARNA is up 32.37%. ARNA lost -$10.14 per share in the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.